# Endostar Combine With Radiotherapy in Brain Metastasis of NSCLC

> **NCT03614065** · PHASE2 · UNKNOWN · sponsor: **Union Hospital, Tongji Medical College, Huazhong University of Science and Technology** · enrollment: 50 (estimated)

## Conditions studied

- Non-small Cell Lung Cancer

## Interventions

- **DRUG:** endostar
- **DRUG:** Placebos
- **RADIATION:** radiotherapy

## Key facts

- **NCT ID:** NCT03614065
- **Lead sponsor:** Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-02-21
- **Primary completion:** 2018-11
- **Final completion:** 2018-11
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2018-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03614065

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03614065, "Endostar Combine With Radiotherapy in Brain Metastasis of NSCLC". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03614065. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*